Glaucoma

Nathan Lighthizer, OD, FAAO, chats about his various Vision Expo West presentations, including an injections workshop, swollen optic nerve course, and new technology case competition.

Jeffry Gerson, OD, FAAO, gives his golden rules on retinal management in two presentations.

Danica Marrelli, OD, FAAO, AAO Dip, gives advice for those looking to upgrade their OCT or integrate the device into their practice.

Ben Casella, OD, FAAO, chief optometric editor for Optometry Times®, gives a preview of what to expect at this year's EyeCon.

In this episode, four expert faculty talk about the importance of early diagnosis and treatment of thyroid eye disease. They discuss the differential diagnosis, screening tests, and the need for multidisciplinary management for these patients.

Injectsense's future plans for the sensor are to fine-tune its delivery tool and incorporate a microbattery into the sensor.

Taking a contemporary approach to prostaglandin analog therapy.

Recent studies that have reported that active and healthy living can reduce IOP.

Some cases require unorthodox approaches.

Long-term vision and ocular surface health are just part of the puzzle.

Topline results from the trial continue to be expected in H2 2025.

From surgeon to mentor: Smith fuels her commitment to improving glaucoma care by training future ophthalmologists.

FYSX is the first non-pharmacological, non-surgical treatment designed to lower IOP for glaucoma patients, according to a news release.

Pathogenesis and detection of diabetic retinopathy.

When audited after completing an education training on the delivery of laser treatments found that optometrists specializing in glaucoma were competent in providing pre- and post-treatment care.

Lorraine Provencher, MD, reviews the NOVA trial which measured and validated the sensitivity of a novel VR-based wearable headset for visual field testing in glaucoma.

North Bay Eye Associates transitions from traditional bowl perimeter to portable vision diagnostic and patient engagement system.

The Tono-Vera Tonometer allows for automated IOP measurements and eliminates the need for a topical anesthetic.

Nazlee Zebardast, MD, MSc, overviews her 2 presentations from ARVO 2024 that utilized polygenic risk scores to identify patients' genetic risk of developing low risk for different glaucoma subtypes.

Michael Chaglasian, OD, details results from a study that assessed the new Monaco OCT's efficacy in glaucoma detection alongside ultra wideview imaging.

At-home devices challenge commonly held beliefs on IOP measurements, visual field testing, and imaging.

The AI-powered model works to detect early signs of glaucoma and makes iHealthScreen the first company to receive 2 US patents for AMD and glaucoma screening devices.

UPFs include fast food, energy drinks and soda, sweets such as chocolates and candies, and much more.

The trials will include patients with ocular hypertension, and assess QLS-111 in its efficacy for lowering IOP beyond levels currently achievable by targeting EVP.

The clinical stage medical technology company is developing a laser system that performs femtosecond laser image-guided high-precision trabeculomtomy, or FLigHT.